---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-000705"
form_type: "8-K/A"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2026-05-11T21:30:26+00:00"
generated_at: "2026-05-11T21:34:41.282222+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lunai Bioworks gets additional Nasdaq delisting notice for MVLS; completes $20M merger

## Summary
- Received Nasdaq staff determination on April 28, 2026 for non-compliance with $35M market value of listed securities (MVLS) rule.
- Completed merger on May 1, 2026, issuing $20M Series B Preferred Stock to support compliance with equity rule.
- Stockholders on May 8, 2026 approved reverse stock split authorization (1:3 to 1:30) to address bid price rule.
- Company requests extension from Nasdaq Hearings Panel for bid price compliance; prior exception expires June 1, 2026.
- Panel previously granted continued listing exception through May 1 (equity) and June 1 (bid price) subject to conditions.

## SEC filing metadata
- accession: 0001731122-26-000705
- form_type: 8-K/A
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2026-05-11T21:30:26+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000705/0001731122-26-000705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000705/e7629_8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-000705
- JSON: https://secwatch.observer/filing/0001731122-26-000705.json
- Plain text: https://secwatch.observer/filing/0001731122-26-000705.txt

## Key facts
- Listing & Compliance Notices
  Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: 5550(b)(2)
  source text: April 28, 2026 of an additional staff determination letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC regarding compliance with Nasdaq Listing Rule 5550(b)(2). The soliciting material and related disclosures included in the Original Report under the captions “The Special Meeting and the Proposals Being Voted On,” “Additional Information and Where to Find It” and “Participants in the Solicitation,” are no longer applicable because the Special Meeting has been held and the proposals submitted to a vote of stockholders thereat have been acted upon. Except as expressly se
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000705/0001731122-26-000705-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.